ANDROMEDA

Related by string. Andromeda * * Gene Roddenberry Andromeda . Andromeda Hero . Andromeda Hero Flower Alley . constellation Andromeda . Princess Andromeda . Andromeda Strain . Andromeda Galaxy . Andromeda galaxy . neighboring Andromeda galaxy . ANDROMEDA 'S HERO Fusaichi . Andromeda Hero ridden . Zito Andromeda Hero . Andromeda Galaxy M# . galaxy Andromeda . Andromeda Biotech *

Related by context. Frequent words. (Click for all words.) 55 phase IIa 54 multicenter randomized double 54 multicentre 54 double blinded placebo 53 Phase III randomized 53 placebo controlled randomized 51 randomized Phase III 51 substudy 51 Randomized 51 prospective observational 50 multicenter randomized 50 placebo controlled clinical 50 multicenter 48 phase IIb 48 Phase 1b clinical 48 NRTI 48 blind randomized placebo 47 Cancer Res 47 label multicenter 46 placebo controlled 46 multicenter study 46 multicenter clinical 46 PRECiSE 46 prospective randomized controlled 46 randomized double 46 blinded placebo controlled 46 Phase IIa trial 46 Phase 2a trial 45 randomized placebo controlled 45 Phase 1b trial 44 double blind placebo 44 REVIVAL 44 Phase 2b study 44 single ascending dose 44 blind randomized controlled 43 prospective randomized 43 events SAEs 43 Phase 2b trial 43 ABSTRACT 43 blind randomized 42 #:#-# [033] 42 randomized controlled 42 composite endpoint 42 mg BID 42 multiple ascending dose 41 cohort 41 CrossRef Medline 41 Phase 1b 41 label dose escalation 41 placebo controlled studies 41 nab paclitaxel 41 vicriviroc 41 neoadjuvant 40 randomized controlled trial 40 randomized controlled clinical 40 SWOG 40 dose cohorts 40 RTOG 40 Cohort 40 tapentadol 40 myocardial infarctions 40 ADHF 40 retrospective cohort study 40 HAMLET 40 subgroup analyzes 40 randomized 40 dose escalation trial 40 ST elevation myocardial 40 placebo controlled trials 39 LEGACY 39 randomized clinical 39 adalimumab 39 ziprasidone 39 prospective cohort 39 castration resistant prostate cancer 39 dose escalation study 38 degli 38 virologic response 38 secondary endpoint 38 CD4 + cell 38 virologic failure 38 MIDNIGHT 38 chemoradiotherapy 38 noninferiority 38 METHODS 38 evaluable patients 37 SENTINEL 37 ECOG 37 dose regimens 37 cytogenetic response 37 evaluable 37 RCTs 37 blind placebo controlled 37 TIMI 37 meta analysis 37 breast carcinoma 37 T2DM 37 ENCORE 36 relapsing remitting 36 post hoc 36 Istituto

Back to home page